rs142722925
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_032444.4(SLX4):c.2332G>C(p.Gly778Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000167 in 1,610,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G778V) has been classified as Uncertain significance.
Frequency
Consequence
NM_032444.4 missense
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group PInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_032444.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLX4 | NM_032444.4 | MANE Select | c.2332G>C | p.Gly778Arg | missense | Exon 12 of 15 | NP_115820.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLX4 | ENST00000294008.4 | TSL:5 MANE Select | c.2332G>C | p.Gly778Arg | missense | Exon 12 of 15 | ENSP00000294008.3 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152208Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000604 AC: 15AN: 248328 AF XY: 0.0000595 show subpopulations
GnomAD4 exome AF: 0.000171 AC: 249AN: 1458504Hom.: 0 Cov.: 36 AF XY: 0.000179 AC XY: 130AN XY: 725748 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000131 AC: 20AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74358 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Fanconi anemia Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 778 of the SLX4 protein (p.Gly778Arg). This variant is present in population databases (rs142722925, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SLX4-related conditions. ClinVar contains an entry for this variant (Variation ID: 526379). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
not provided Uncertain:1
DNA sequence analysis of the SLX4 gene demonstrated a sequence change, c.2332G>C, in exon 12 that results in an amino acid change, p.Gly778Arg. This sequence change does not appear to have been previously described in individuals with SLX4-related disorders. This sequence change has been described in the gnomAD database with a frequency of 0.01% in the European subpopulation (dbSNP rs142722925). The p.Gly778Arg change affects a highly conserved amino acid residue located in a domain of the SLX4 protein that is known to be functional. The p.Gly778Arg substitution appears to be deleterious sing several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Gly778Arg change remains unknown at this time.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at